TrialEuropean urology2022

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.

Bernadett Szabados et al.PubMed ↗Publisher ↗

No numbers read from the abstract.